HYPERLIPOPROTEINEMIA AS A SIGNIFICANT RISK FACTOR FOR PULMONARY-EMBOLISM IN PATIENTS UNDERGOING CORONARY-ARTERY BYPASS-GRAFTING

被引:12
作者
HANSON, EC [1 ]
LEVINE, FH [1 ]
机构
[1] HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, DEPT SURG, BOSTON, MA 02114 USA
关键词
D O I
10.1016/S0003-4975(10)60818-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:593 / 598
页数:6
相关论文
共 19 条
[1]  
ANDERSEN P, 1976, ACTA MED SCAND, V200, P289
[2]   CLINICAL FEATURES OF SUBMASSIVE AND MASSIVE PULMONARY EMBOLI [J].
BELL, WR ;
SIMON, TL ;
DEMETS, DL .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (03) :355-360
[3]   EFFECT OF CLOFIBRATE ON INTRAVASCULAR COAGULATION IN HYPERLIPOPROTEINEMIA [J].
CARVALHO, AC ;
LEES, RS ;
VAILLANCOURT, RA ;
COLMAN, RW .
CIRCULATION, 1977, 56 (01) :114-118
[4]   CLOFIBRATE REVERSAL OF PLATELET HYPERSENSITIVITY IN HYPERBETALIPOPROTEINEMIA [J].
CARVALHO, AC ;
COLMAN, RW ;
LEES, RS .
CIRCULATION, 1974, 50 (03) :570-574
[5]   INCREASED ACTIVITY OF VITAMIN-K-DEPENDENT CLOTTING FACTORS IN HUMAN HYPERLIPOPROTEINEMIA - ASSOCIATION WITH CHOLESTEROL AND TRIGLYCERIDE LEVELS [J].
CONSTANTINO, M ;
MERSKEY, C ;
KUDZMA, DJ ;
ZUCKER, MB .
THROMBOSIS AND HAEMOSTASIS, 1977, 38 (02) :465-474
[6]   PLASMA FACTOR-13 AND PLATELET FACTOR-13 IN HYPERLIPEMIA [J].
CUCUIANU, MP ;
MILOSZEWSKI, K ;
PORUTIU, D ;
LOSOWSKY, MS .
THROMBOSIS AND HAEMOSTASIS, 1976, 36 (03) :542-550
[7]   A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA [J].
FREDRICK.DS ;
LEES, RS .
CIRCULATION, 1965, 31 (03) :321-&
[8]  
HALL RJ, 1973, CIRCULATION S3, V48, P146
[9]  
HANSON EC, 1980, J THORAC CARDIOV SUR, V79, P372
[10]  
HAWE A, 1969, CIRCULATION, V39, pI185